This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Texas A&M University System, The University of Texas System. Active years: 2023.
Company Filing History:

Years Active: 2023
Title: Elizabeth Gardner: Innovator in Metabolite Screening Technologies
Introduction
Elizabeth Gardner is a prominent inventor based in Austin, TX (US). She has made significant contributions to the field of metabolite screening and selection through her innovative methods and platforms. Her work has implications for various applications in biotechnology and pharmaceuticals.
Latest Patents
Elizabeth Gardner holds a patent for "Methods and platform for screening and selecting metabolites and their receptors." This patent discloses methods and platforms utilizing Receptor Compartmentalized Partnered Replication (CPR). In this process, the partner gene is a receptor, signal transduction pathway, or metabolic pathway that leads to the production of an effector molecule. The signal transduction pathway or receptor is coupled to the production of a thermostable polymerase. The emulsification of libraries of organisms with primers that can amplify the partner gene allows for the selective amplification of those partner genes that are most effective in producing the thermostable polymerase during thermal cycling of the emulsion.
Career Highlights
Throughout her career, Elizabeth has worked with esteemed institutions such as the University of Texas System and Texas A&M University System. Her experience in these organizations has allowed her to develop and refine her innovative approaches to metabolite screening.
Collaborations
Elizabeth has collaborated with notable colleagues, including Jimmy Gollihar and Katy Kao. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Elizabeth Gardner is a trailblazer in the field of metabolite screening technologies. Her innovative patent and collaborations with leading institutions and colleagues highlight her significant impact on the industry.